APA (7th ed.) Citation

A, P., SZ, W., TR, F., KJ, M., A, O., J, A., . . . JA, R. (2022). Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors. Cell death & disease, 13(4), 410. https://doi.org/10.1038/s41419-022-04868-9

Chicago Style (17th ed.) Citation

A, Parkhurst, et al. "Dual MTORC1/2 Inhibition Compromises Cell Defenses Against Exogenous Stress Potentiating Obatoclax-induced Cytotoxicity in Atypical Teratoid/rhabdoid Tumors." Cell Death & Disease 13, no. 4 (2022): 410. https://doi.org/10.1038/s41419-022-04868-9.

MLA (9th ed.) Citation

A, Parkhurst, et al. "Dual MTORC1/2 Inhibition Compromises Cell Defenses Against Exogenous Stress Potentiating Obatoclax-induced Cytotoxicity in Atypical Teratoid/rhabdoid Tumors." Cell Death & Disease, vol. 13, no. 4, 2022, p. 410, https://doi.org/10.1038/s41419-022-04868-9.

Warning: These citations may not always be 100% accurate.